Month: September 2023

NANOBIOTIX Announces Oral Presentation of Final Results From a Phase 1 Dose Expansion Study Evaluating NBTXR3 in Head and Neck Cancer at the 65th Annual Meeting of the American Society for Radiation Oncology

Infinx Healthcare Recognized as a Sample Vendor for Intelligent Prior Authorization for Second Year in a Row in the Gartner Hype Cycle for U.S. Healthcare Payers, 2023

Gartner Hype Cycle Recognizes Infinx Healthcare as a Sample Vendor for Intelligent Prior AuthorizationNEW YORK, NY / ACCESSWIRE / September...

error: Content is protected !!